Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

Sponsor
Shandong Suncadia Medicine Co., Ltd.
Study ID
NCT06727838
Phase
PHASE1
Status
Completed

Conditions

  • Diabetes

Eligibility Criteria

Sex
MALE
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • HRS-7535 tablets — DRUG
    HRS-7535 tablets.
  • Metformin Hydrochloride Extended-release Tablets — DRUG
    Metformin Hydrochloride Extended-release Tablets.
  • Metformin Hydrochloride Tablets — DRUG
    Metformin Hydrochloride Tablets.

Study Details

This study was a single-center, open, fixed-sequence, self-controlled trial design conducted in healthy subjects.

Key Dates

Start date
Dec 31, 2024
Status verified
Apr 2026
Primary completion
Jan 25, 2025
Completion
Jan 25, 2025

Study Design

Enrollment
18 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment group

Primary Outcome Measure

Maximum plasma concentration (Cmax) [ Time Frame: 0 hour to 24 hours after the last dosing. ]

Related Studies